Elson S. Floyd College of Medicine, and Office of Research (Spokane) – Departmental Page
email@example.com – Roll, John
Co-occurring Disorders/Affective Neuroscience/Addiction
John Roll earned a Bachelor of Psychology degree from the University of Montana, a Master of Arts degree in psychology from Saint Bonaventure University, and a Ph.D. in Experimental Psychology from Washington State University. He completed a Postdoctoral Fellowship in Human Behavioral Pharmacology at the University of Vermont and a Postdoctoral Fellowship in Substance Abuse Research at the University of Michigan Ann Arbor. He has served as a faculty member in the Department of Psychiatry at Wayne State University, Director of Behavioral Pharmacology in UCLA’s Integrated Substance Abuse Programs, and as Director of the Washington Institute for Mental Health Research and Training. He is currently a Professor and Associate Dean for Research in the WSU College of Nursing. He is also Director of the Program of Excellence in the Addictions and the Program of Excellence in Rural Mental Health and Substance Abuse Treatment. Dr. Roll holds additional appointments in the WSU Departments of Psychology, neuroscience, health policy administration and the University of Washington School of Medicine. He was been appointed by Governor Gregoire as an Executive Commissioner on the Eastern State Hospital Advisory Board and as a Vice Chair of the Governor’s Council on Substance Abuse. Dr. Roll served as a permanent member of the NIDA K review committee and has served as an ad hoc reviewer for many other NIH review committees. He has also served as a reviewer for CDC, SAMHSA, DVA, and the Parkinson’s and Movement Disorder Foundation. Dr. Roll’s work has focused on human behavioral pharmacology, the development and refinement of behavioral interventions for addiction and other psychiatric disorders, as well as technology transfer issues. His research is currently funded by NIH, DOJ, SAMHSA, CDC, BJA and WA State Life Science’s Discovery Fund. Dr. Roll is a Fellow of the American Psychological Association and served as President of the American Psychological Association’s Division on Psychopharmacology and Substance Abuse.